Received Aug 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | A5573 | — |
Infanrix administered after recommended age; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 7-year-old female patient who received DTPa (Infanrix) (batch number A5573, expiry date 13-JUL-2025) for prophylaxis. Previously administered products included Pediarix and Kinrix. On 16-JAN-2025, the patient received Infanrix. On 16-JAN-2025, an unknown time after receiving Infanrix, the patient experienced inappropriate age at vaccine administration (Verbatim: Infanrix administered after recommended age). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 22-JUL-2025 The nurse called on 22nd July 2025, to report that a 7-year-old patient had received Infanrix on 16th January 2025, which led to Inappropriate age at vaccine administration. The nurse explained that the incident had been discovered while reviewing a billing claim.